Yale Engage Cancer Series: Immuno-Oncolocgy

In conjunction with Yale Cancer Center, we present Yale Engage, an interactive webinar series promoting impactful collaboration between academic experts and industry executives. This is designed for a broad corporate audience, but particularly of interest for executives and leaders in Research & Development, Business Development, Strategy, and Innovation in sectors such as Biotechnology, Pharmaceutical, Healthcare, Technology, and Venture Capital.

These sessions will feature corporate speakers with a panel of renowned Yale physicians and scientists addressing critical challenges.

With real-time dialogue and strategic introductions, we will pinpoint issues and research goals to advance shared, scalable solutions.  In the fight against cancer, Yale Cancer Center is at the forefront of understanding the fundamental mechanisms of cancer biology and in developing effective cancer treatment therapies.  The Cancer Center harnesses the resources of the Yale School of Medicine and Smilow Cancer Hospital at Yale New Haven to advance cancer research, prevention, and patient care, as well as community outreach and education.

Immuno-Oncology    
The discussion will highlight current and ongoing collaborative science at Yale, including basic Immunobiology and discovery through tools that identify mechanisms of action.

Moderator: Mario Sznol, MD, Professor of Medicine (Medical Oncology), Yale School of Medicine; Co-Leader, Cancer Immunology, Yale Cancer Center; Leader, Yale Melanoma Program
Panelists from the Yale School of Medicine:

• Marcus Bosenberg, MD, PhD
• Grace Chen, PhD
• Roy Herbst, MD, PhD
• Akiko Iwasaki, PhD
• Aaron Ring, MD, PhD